They were initially aimed at treating patients with type 2 diabetes, but some are now developed specifically to treat obesity
Lesser Highlights CTs Generic GLP-1 Legislation at National Conference Today, State Senator Matt Lesser , Senate Chair of the Human Services Committee, spoke at the National Academy for State Health Policy (NASHP) Annual Health Policy Conference in San Diego on Connecticuts recently enacted bipartisan prescription drug law, which puts Connecticut in the front of the pack of states in controlling drug costs
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD-2)
519 Ultimately, GLP-1RA, by regulating BMP4 and its effects on cell proliferation and metastasis, provides a promising treatment approach
Microdosing seems to be overwhelmingly targeted to women who either dont qualify for prescription GLP-1s, and/or have very little to no weight to lose (which is why they dont qualify for the rx in the first place)
Some patients take them long-term for maintenance, while others taper off under medical guidance after achieving goals
